What is the ICD-10 (International Classification of Diseases, 10th Revision) code for screening for Sexually Transmitted Diseases (STDs)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Code for STD Screening

The ICD-10 code for screening for sexually transmitted diseases in asymptomatic patients is Z11.3 1.

Primary Screening Code

  • Z11.3 is the designated code for encounters specifically for screening for sexually transmitted infections (STIs) in asymptomatic patients 1.
  • This code should be used for all routine STD screening encounters, regardless of the specific infections being tested for 1.

When to Use Z11.3

  • All sexually active females under 25 years receiving annual chlamydia and gonorrhea screening should be coded with Z11.3 1.
  • Young sexually active men undergoing routine screening, particularly in settings where STI prevalence is ≥2%, should be coded with Z11.3 1.
  • Persons entering correctional facilities being screened for syphilis, gonorrhea, and chlamydia should be coded with Z11.3 1.
  • Adolescents in institutional settings undergoing screening when prevalence is ≥2% should be coded with Z11.3 1.

Critical Coding Pitfall to Avoid

  • Pap tests should NOT be considered screening tests for STDs and should not be coded with Z11.3 1.
  • This is a common error—cervical cancer screening and STD screening are distinct services requiring different coding 1.

Clinical Context

  • The Z11.3 code applies to asymptomatic screening encounters, not diagnostic testing for symptomatic patients or follow-up testing after known exposure 1.
  • This code supports the CDC's recommendation for universal screening of sexually active women under 25 years, which has been a best practice since 1997 and leads to decreased disease prevalence and serious sequelae like pelvic inflammatory disease 2.
  • Proper coding with Z11.3 facilitates tracking of screening rates, which historically fail to approach recommended levels in actual clinical practice 2.

References

Guideline

STD Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sexually transmitted disease screening in teens.

Current women's health reports, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.